BMF Biotechnology
Enhanced drug discovery and cosmetic testing accuracy with micro-precision 3D printing technology
BMF Biotechnology is focused on developing advanced organ-on-a-chip platforms for enhanced recapitulation of physiologically relevant tissues by leveraging BMF’s state of the art 3D printing technology. Our perfusable organ-on-a-chip platforms have the potential to improve drug discovery and cosmetic testing outcomes, as well as advancing the precision medicine.
Organ Chip for Drug Discovery and Cosmetics Testing
At BMF Biotechnology, we are committed to making drug discovery and cosmetology more accurate, time efficient, and cheaper. We are developing tumor-on-a-chip, skin-on-a-chip, and kidney-on-a-chip models that will provide a more reliable and cost-effective alternative to animal testing. Our mission is to create a better future for all.
A10 BioChip
A highly perfusable platform for the formation of thick and dense tissues
Features
- Perfusion covered volume: 10mm x 6mm x 3mm.
- 70 porous microchannels (120μm OD, 80μm ID, ~7μm pores).
- Perfusion for nutrients & waste exchange through the channels.
- Drug distribution in the depth of the tissue, through the channels.
- Top open chamber for easy cell loading.
Benefits
- Easy to visualize tissue.
- In vivo-relevant tissue morphologie and functionalities.
- Improved prediction of in vivo compound response.
- Save time and costs for drug and cosmetic development.
BMF Biotechnology is looking for collaborators
BMF is now seeking collaborators to work together to further refine concepts, test and validate performance and pinpoint applications that would benefit the most from our BioChip technology. Interested in learning more?
Contact usC10 BioChip
A beginner-friendly platform for large tissue formation
Features
- Perfusion covered volume: 10mm x 6mm x 2mm.
- 2 layers of porous microchannels with ~7μm pores
- 2 available channels dimension options:
- 1) 12 total microchannels, 600μm OD, 500μm ID, 400 μm distancing
- 2) 16 total microchannels, 500μm OD, 400μm ID, 200 μm distancing
- Distribution of nutrients and drugs & waste exchange through the entire tissue.
- Top open chamber for easy cell loading.
Benefits
- Beginner friendly.
- Easy to visualize tissue.
- Cell and organoid on-chip culture.
- Improved prediction of in vivo compound response.
- Save time and costs for drug and cosmetic development.
The launch of BMF Biotechnology Inc. represents a significant leap forward in our ability to harness the potential of 3D BioChip technology. With our innovative approach, we aim to empower researchers with the tools they need to translate scientific discoveries into tangible therapeutic solutions that improve patient outcomes.
– Dr. Jennifer Sun, Chief Scientific Officer of BMF Biotechnology